In an ongoing process with the Notified Body (NB) Intertek, PolarCool has made important progress in obtaining approval for the company's own quality management system ISO 13485 within the new MDR regulations. Intertek has provided PolarCool with a timeline for the upcoming certification process, the first part of which will begin in this autumn. The final part, which is a stage 2 audit, is planned to take place during June 2023. This is the last step for PolarCool in obtaining its own MDR certificate.

Today, PolarCool's med-tech product PolarCap® System is certified through the current cooperation agreement with BrainCool AB, which means that the product is manufactured and sold under BrainCool's QMS for quality assurance. When PolarCool receives its own approval, the product will be transferred to the company's own QMS.

PolarCool CEO Erik Andersson comments:

-The fact that we have now received a slot, and a timeline from Intertek means that we have taken a big step closer to our long goal of having our own QMS. The new MDR regulations from the EU place a very heavy burden on the Notified Bodies that issue certificates, which has resulted in a long queue time to start the process.

-At the same time, the current cooperation agreement with BrainCool has given us the opportunity to use their QMS, allowing us to be able to market and sell our product in Europe.

PolarCool develops and markets the product PolarCap® which alleviates the effects of concussion. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, and handball, but also other sports with an increased risk of concussion.